<!DOCTYPE html>

<html>
  <head>
    <title>BCNscreening</title>
    <meta charset="utf-8" />
    <meta
      name="viewport"
      content="width=device-width, initial-scale=1, user-scalable=no"
    />
    <link rel="stylesheet" href="assets/css/main.css" />
  </head>
  <body class="is-preload">
  
    <div id="page-wrapper">
      <!-- Wrapper -->
      <div class="wrapper">
        <div class="inner">
          <!-- Header -->
          <header id="header">
            <span class="miga"
            ><a href="index.html"><span class="depan">MÓDULO 7</span>&nbsp;</a
            ><span
              ><a href="M7biblio.html"
                ><i class="arrow right"></i>&nbsp;&nbsp;<span class="depan1"
                  >Bibliografía</span
                ></a
              ></span
            ></span
          >
            <nav>
              <ul>
                <li><a href="#menu"></a></li>
              </ul>
            </nav>

          </header>

          <!-- Nav -->

          <nav id="menu">
            <h4>ÍNDICE</h4>

            <ul class="links">
              <li><a href="M71_1.html">&nbspUnidad 1</a></li>
              <li><a href="M72_1.html">&nbspUnidad 2</a></li>
              <li><a href="M73.html">&nbspUnidad 3</a></li>
            </ul>
            <h4>RECURSOS</h4>
            <ul class="links">
              <li><a href="M7summary.html">&nbspGlosario</a></li>
              <li><a href="M7biblio.html">&nbspBibliografía</a></li>
              <li>
                <a href="docs/PDFsample.pdf" target="_blank"
                  >&nbspContenido en PDF</a
                >
              </li>
            </ul>
          </nav>
          <!-- Summary -->
          <section class="main">
            <header class="major">
              <h1>BIBLIOGRAFÍA</h1>
                </header>
                <ol class="alt">
                  <li>Looker KJ, Rönn MM, Brock PM, Brisson M, Drolet M, Mayaud P, et al. Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status. J Int AIDS Soc 2018;21:e25110.</li>
                  <li>Hawes SE, Critchlow CW, Sow PS, Touré P, N’Doye I, Diop A, et al. Incident High-Grade Squamous Intraepithelial Lesions in Senegalese Women With and Without Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2. JNCI: Journal of the National Cancer Institute 2006;98:100–9.</li>
                  <li>Denslow SA, Rositch AF, Firnhaber C, Ting J, Smith JS. Incidence and progression of cervical lesions in women with HIV: a systematic global review. Int J STD AIDS 2014;25:163–77.</li>
                  <li>Stelzle D, Tanaka LF, Lee KK, Khalil AI, Baussano I, Shah ASV, et al. Estimates of the global burden of cervical cancer associated with HIV. The Lancet Global Health [Internet] 2020 [cited 2020 Nov 17];0. Disponible <a
                    href="https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30459-9/abstract"
                    class=""
                    target="_blank"
                    >aquí
                    <span class="icon solid fa-external-link-alt"></span
                  ></a>.</li>
                  <li>Castro KG, Ward JW, Slutsker L, Buehler JW, Jaffe HW, Berkelman RL, et al. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41:1–19.</li>
                  <li>Debeaudrap P, Sobngwi J, Tebeu P-M, Clifford GM. Residual or Recurrent Precancerous Lesions After Treatment of Cervical Lesions in Human Immunodeficiency Virus-infected Women: A Systematic Review and Meta-analysis of Treatment Failure. Clin Infect Dis 2019;69:1555–65.</li>
                  <li>Dryden-Peterson S, Bvochora-Nsingo M, Suneja G, Efstathiou JA, Grover S, Chiyapo S, et al. HIV Infection and Survival Among Women With Cervical Cancer. J Clin Oncol 2016;34:3749–57.</li>
                  <li>Mudini W, Palefsky JM, Hale MJ, Chirenje MZ, Makunike-Mutasa R, Mutisi F, et al. Human Papillomavirus Genotypes in Invasive Cervical Carcinoma in HIV-Seropositive and HIV-Seronegative Women in Zimbabwe. J Acquir Immune Defic Syndr 2018;79:e1–6.</li>
                  <li>Rudd P, Gorman D, Meja S, Mtonga P, Jere Y, Chidothe I, et al. Cervical cancer in southern Malawi: A prospective analysis of presentation, management, and outcomes. Malawi Med J 2017;29:124–9.</li>
                  <li>van Aardt M, Dreyer G, Pienaar H, Karlsen F, Hovland S, Richter K, et al. Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection. Int J Gynecol Cancer 2015;25:919–25.</li>
                  <li>Kahesa C, Mwaiselage J, Wabinga HR, Ngoma T, Kalyango JN, Karamagi CAS. Association between invasive cancer of the cervix and HIV-1 infection in Tanzania: the need for dual screening. BMC Public Health 2008;8:262.</li>
                  <li>Gichangi PB, Bwayo J, Estambale B, De Vuyst H, Ojwang S, Rogo K, et al. Impact of HIV infection on invasive cervical cancer in Kenyan women. AIDS 2003;17:1963–8.</li>
                  <li>Moodley M, Mould S. Invasive cervical cancer and human immunodeficiency virus (HIV) infection in KwaZulu-Natal, South Africa. J Obstet Gynaecol 2005;25:706–10.</li>
                  <li>Moodley M, Moodley J, Kleinschmidt I. Invasive cervical cancer and human immunodeficiency virus (HIV) infection: a South African perspective. Int J Gynecol Cancer 2001;11:194–7.</li>
                  <li>Arbyn M, Weiderpass E, Bruni L, Sanjosé S de, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. The Lancet Global Health 2020;8:e191–203.</li>
                  <li>Moscicki A-B, Flowers L, Huchko MJ, Long ME, MacLaughlin KL, Murphy J, et al. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection. J Low Genit Tract Dis 2019;23:87–101.</li>
                  <li>Beachler DC, Jenkins G, Safaeian M, Kreimer AR, Wentzensen N. Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis. J. Infect. Dis. 2016;213:1444–54.</li>
                  <li>Joint United Nations Programme on HIV/AIDS (UNAIDS). AIDSinfo | UNAIDS [Internet]. 2020 [cited 2020 Nov 26]; Disponible <a
                    href="https://aidsinfo.unaids.org/"
                    class=""
                    target="_blank"
                    >aquí
                    <span class="icon solid fa-external-link-alt"></span
                  ></a>.</li>
                  <li>Clifford GM, Gonçalves MAG, Franceschi S, HPV and HIV Study Group. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 2006;20:2337–44.</li>
                <li>Clifford GM, de Vuyst H, Tenet V, Plummer M, Tully S, Franceschi S. Effect of HIV Infection on Human Papillomavirus Types Causing Invasive Cervical Cancer in Africa. J Acquir Immune Defic Syndr 2016;73:332–9.</li>
                <li>Guiguet M, Boué F, Cadranel J, Lang J-M, Rosenthal E, Costagliola D, et al. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol 2009;10:1152–9.</li>
                <li>Clifford GM, Franceschi S, Keiser O, Schöni-Affolter F, Lise M, Dehler S, et al. Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study. Int. J. Cancer 2016;138:1732–40.</li>
                  <li>Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 2006;110:525–41. 
                </li><li>Woodman CBJ, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat. Rev. Cancer 2007;7:11–22. 
                </li><li>Black APB, Ardern‐Jones MR, Kasprowicz V, Bowness P, Jones L, Bailey AS, et al. Human keratinocyte induction of rapid effector function in antigen-specific memory CD4+ and CD8+ T cells. European Journal of Immunology 2007;37:1485–93. 
                </li><li>Moerman-Herzog A, Nakagawa M. Early Defensive Mechanisms against Human Papillomavirus Infection. Clin Vaccine Immunol 2015;22:850–7. 
                </li><li>Wu TC, Kurman RJ. Analysis of cytokine profiles in patients with human papillomavirus-associated neoplasms. J Natl Cancer Inst 1997;89:185–7. 
                </li><li>Langers I, Renoux V, Reschner A, Touzé A, Coursaget P, Boniver J, et al. Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancer. European Journal of Immunology 2014;44:3585–95. 
                </li><li>Jacobs R, Heiken H, Schmidt RE. Mutual interference of HIV and natural killer cell-mediated immune response. Mol Immunol 2005;42:239–49. 
                </li><li>Kobayashi A, Greenblatt RM, Anastos K, Minkoff H, Massad LS, Young M, et al. Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection. Cancer Res 2004;64:6766–74. 
                </li><li>Chen Y-C, Li C-Y, Liu H-Y, Lee N-Y, Ko W-C, Ko N-Y. Effect of antiretroviral therapy on the incidence of cervical neoplasia among HIV-infected women: a population-based cohort study in Taiwan. AIDS 2014;28:709–15. 
                </li><li>Kelly H, Weiss HA, Benavente Y, de Sanjose S, Mayaud P, ART and HPV Review Group. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis. Lancet HIV 2018;5:e45–58. 
                </li><li>INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, et al. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med 2015;373:795–807. 
                </li><li>Borges ÁH, Neuhaus J, Babiker AG, Henry K, Jain MK, Palfreeman A, et al. Immediate Antiretroviral Therapy Reduces Risk of Infection-Related Cancer During Early HIV Infection. Clin Infect Dis 2016;63:1668–76. 
                </li><li>Joint United Nations Programme on HIV/AIDS (UNAIDS). 90–90–90 - An ambitious treatment target to help end the AIDS epidemic [Internet]. 2014 [cited 2021 Feb 16]. Disponible <a
                  href="https://www.unaids.org/en/resources/documents/2017/90-90-90"
                  class=""
                  target="_blank"
                  >aquí
                  <span class="icon solid fa-external-link-alt"></span
                ></a>.</li>
                <li>Rohner E, Bütikofer L, Schmidlin K, Sengayi M, Maskew M, Giddy J, et al. Cervical cancer risk in women living with HIV across four continents: A multicohort study. Int J Cancer 2020;146:601–9. 
                </li><li>Clifford GM, Tully S, Franceschi S. Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer. Clin Infect Dis 2017;64:1228–35. 
                </li><li>Huchko MJ, Sneden J, Sawaya G, Smith-McCune K, Maloba M, Abdulrahim N, et al. Accuracy of Visual Inspection with Acetic Acid to detect Cervical Cancer Precursors Among HIV-infected Women in Kenya. Int J Cancer 2015;136:392–8. 
                </li><li>Bateman AC, Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Kapambwe S, Katundu K, et al. Clinical Performance of Digital Cervicography and Cytology for Cervical Cancer Screening in HIV-infected Women in Lusaka, Zambia. J Acquir Immune Defic Syndr 2014;67:212–5. 
                </li><li>Firnhaber C, Mayisela N, Mao L, Williams S, Swarts A, Faesen M, et al. Validation of Cervical Cancer Screening Methods in HIV Positive Women from Johannesburg South Africa. PLOS ONE 2013;8:e53494. 
                </li><li>Joshi S, Sankaranarayanan R, Muwonge R, Kulkarni V, Somanathan T, Divate U. Screening of cervical neoplasia in HIV-infected women in India. AIDS 2013;27:607–15. 
                </li><li>Chibwesha CJ, Frett B, Katundu K, Bateman AC, Shibemba A, Kapambwe S, et al. Clinical Performance Validation of 4 Point-of-Care Cervical Cancer Screening Tests in HIV-Infected Women in Zambia. J Low Genit Tract Dis 2016;
                </li><li>Fokom Domgue J, Valea FA. Is It Relevant to Keep Advocating Visual Inspection of the Cervix With Acetic Acid for Primary Cervical Cancer Screening in Limited-Resource Settings? J Glob Oncol 2018;4:1–5. 
                </li><li>Ndizeye Z, Menon S, Van Geertruyden J-P, Sauvaget C, Jacquemyn Y, Bogers J-P, et al. Performance of OncoE6TM Cervical Test in detecting cervical precancer lesions in HIV-positive women attending an HIV clinic in Bujumbura, Burundi: a cross-sectional study. BMJ Open 2019;9:e029088. 
                </li><li>Bansil P, Lim J, Byamugisha J, Kumakech E, Nakisige C, Jeronimo JA. Performance of Cervical Cancer Screening Techniques in HIV-Infected Women in Uganda. J Low Genit Tract Dis 2015;19:215–9. 
                </li><li>Sahasrabuddhe VV, Bhosale RA, Kavatkar AN, Nagwanshi CA, Joshi SN, Jenkins CA, et al. Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India. Int J Cancer 2012;130:234–40. 
                </li><li>Hu L, Bell D, Antani S, Xue Z, Yu K, Horning MP, et al. An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening. J Natl Cancer Inst 2019;11:923–32. 
                </li><li>Mabeya H, Khozaim K, Liu T, Orango O, Chumba D, Pisharodi L, et al. Comparison of Conventional Cervical Cytology versus Visual Inspection with Acetic Acid (VIA) among HIV-Infected Women in Western Kenya. J Low Genit Tract Dis 2012;16:92–7. 
                </li><li>Segondy M, Kelly H, Magooa MP, Djigma F, Ngou J, Gilham C, et al. Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study. Br J Cancer 2016;115:425–30. 
                </li><li>Chung MH, McKenzie KP, De Vuyst H, Richardson BA, Rana F, Pamnani R, et al. Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapy. AIDS 2013;27:2909–19. 
                </li><li>Kelly HA, Chikandiwa A, Sawadogo B, Gilham C, Michelow P, Lompo OG, et al. Diagnostic accuracy of cervical cancer screening and screening–triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study. PLoS Med [Internet] 2021 [cited 2021 Apr 27];18. Disponible <a
                  href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971880/"
                  class=""
                  target="_blank"
                  >aquí
                  <span class="icon solid fa-external-link-alt"></span
                ></a>.</li> 
                </li><li>Giorgi-Rossi P, Franceschi S, Ronco G. HPV prevalence and accuracy of HPV testing to detect high-grade cervical intraepithelial neoplasia. Int. J. Cancer 2012;130:1387–94. 
                </li><li>de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010;11:1048–56. 
                </li><li>Kuhn L, Saidu R, Boa R, Tergas A, Moodley J, Persing D, et al. Clinical evaluation of modifications to a human papillomavirus assay to optimise its utility for cervical cancer screening in low-resource settings: a diagnostic accuracy study. The Lancet Global Health 2020;8:e296–304. 
                </li><li>Kuhn L, Wang C, Tsai W-Y, Wright TC, Denny L. Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women. AIDS 2010;24:2553–61. 
                </li><li>Firnhaber C, Mayisela N, Mao L, Williams S, Swarts A, Faesen M, et al. Validation of Cervical Cancer Screening Methods in HIV Positive Women from Johannesburg South Africa. PLOS ONE 2013;8:e53494. 
                </li><li>Joshi S, Muwonge R, Kulkarni V, Deodhar K, Mandolkar M, Lucas E, et al. Incidence of cervical intraepithelial neoplasia in women infected with human immunodeficiency virus (HIV) with no evidence of disease at baseline: results of a prospective cohort study with up to 6.4 years of follow-up from India. Int. J. Cancer 2018;
                </li><li>Kremer WW, Steenbergen RDM, Heideman D a. M, Kenter GG, Meijer C. The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review. BJOG: An International Journal of Obstetrics & Gynaecology 2021;128:504–14. 
                </li><li>Kelly H, Benavente Y, Pavon MA, De Sanjose S, Mayaud P, Lorincz AT. Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis. Br J Cancer 2019;121:954–65. 
                </li><li>Zummeren MV, Kremer WW, Aardt MCV, Breytenbach E, Richter KL, Rozendaal L, et al. Selection of women at risk for cervical cancer in an HIV-infected South African population. AIDS 2017;31:1945–53. 
                </li><li>De Vuyst H, Franceschi S, Plummer M, Mugo NR, Sakr SR, Meijer CJLM, et al. Methylation Levels of CADM1, MAL, and MIR124-2 in Cervical Scrapes for Triage of HIV-Infected, High-Risk HPV-Positive Women in Kenya. J. Acquir. Immune Defic. Syndr. 2015;70:311–8. 
                </li><li>Kremer WW, Van Zummeren M, Breytenbach E, Richter KL, Steenbergen RDM, Meijer CJLM, et al. The use of molecular markers for cervical screening of women living with hiv in South Africa. AIDS 2019;
                </li><li>Strickler HD, Keller MJ, Hessol NA, Eltoum I-E, Einstein MH, Castle PE, et al. Primary HPV and Molecular Cervical Cancer Screening in US Women Living with HIV. Clin Infect Dis 2020;
                </li><li>Rezhake R, Hu S-Y, Zhao S, Xu X-Q, Zhao X-L, Zhang L, et al. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women. Int J Cancer 2019;144:34–42. 
                </li><li>McDonald AC, Tergas AI, Kuhn L, Denny L, Wright TC. Distribution of Human Papillomavirus Genotypes among HIV-Positive and HIV-Negative Women in Cape Town, South Africa. Front Oncol 2014;4:48. 
                </li><li>Atemnkeng N, Aji AD, de Sanjose S, Mayaud P, Kelly H. Antiretroviral therapy and detection of high-grade cervical intraepithelial neoplasia (CIN2+) at post-CIN management follow-up among women living with HIV: a systematic review and meta-analysis. Clin Infect Dis 2020;
                </li><li>Omenge Orang’o E, Liu T, Christoffersen-Deb A, Itsura P, Oguda J, Washington S, et al. Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities. AIDS 2017;31:233–40. 
                </li><li>De Vuyst H, Mugo NR, Franceschi S, McKenzie K, Tenet V, Njoroge J, et al. Residual Disease and HPV Persistence after Cryotherapy for Cervical Intraepithelial Neoplasia Grade 2/3 in HIV-Positive Women in Kenya. PLoS One [Internet] 2014 [cited 2021 Feb 16];9. Disponible <a
                  href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208814/"
                  class=""
                  target="_blank"
                  >aquí
                  <span class="icon solid fa-external-link-alt"></span
                ></a>.</li> 
                <li>National cervical cancer screening programs and coverage worldwide. [Internet]. Barcelona (online): 2020. Disponible <a
                  href="https://ipvconference.org/wp-content/uploads/sites/40/2020/09/IPVC20_-_Abstracts-final.pdf"
                  class=""
                  target="_blank"
                  >aquí
                  <span class="icon solid fa-external-link-alt"></span
                ></a>.</li>
                </li><li>Jemal A, Bray F, Forman D, O’Brien M, Ferlay J, Center M, et al. Cancer burden in Africa and opportunities for prevention. Cancer 2012;118:4372–84. 
                </li><li>Sigfrid L, Murphy G, Haldane V, Chuah FLH, Ong SE, Cervero-Liceras F, et al. Integrating cervical cancer with HIV healthcare services: A systematic review. PLoS One 2017;12:e0181156. 
                </li><li>Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007;370:59–67. 
                </li><li>Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 2012;13:487–500. 
                </li><li>Clifford GM, Georges D, Shiels MS, Engels EA, Albuquerque A, Poynten IM, et al. A meta-analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale. Int J Cancer 2021;148:38–47. 
                </li><li>New York State Health Department of Health AIDS Institute. Screening for Anal Dysplasia and Cancer in Patients with HIV [Internet]. 2020 [cited 2021 Feb 16]. Disponible <a
                  href="https://www.hivguidelines.org/hiv-care/anal-dysplasia-cancer/"
                  class=""
                  target="_blank"
                  >aquí
                  <span class="icon solid fa-external-link-alt"></span
                ></a>.</li>
                </li><li>Delfraissy J-F, Expert group. Management of patients infected by the human immunodeficiency virus (HIV). Report of an expert group. Rev Pneumol Clin 2002;58:312–40. 
                </li><li>Blanco JL, Blanco JR, Camino X, Curran A, Merchante A, Díaz A, et al. Documento de consenso sobre diagnóstico y tratamiento de las infecciones de transmisión sexual en adultos, niños y adolescentes [Internet]. 2017 [cited 2021 Feb 16]; Disponible <a
                  href="http://gesida-seimc.org/category/guias-clinicas/otras-guias-vigentes/page/2/"
                  class=""
                  target="_blank"
                  >aquí
                  <span class="icon solid fa-external-link-alt"></span
                ></a>.</li> 
                </li><li>European AIDS Clinical Society Guidelines 2019, versión 10.0 [Internet]. Available from: 2019_guidelines-10.0_final.pdf (eacsociety.org)
                </li><li>Stewart DB, Gaertner WB, Glasgow SC, Herzig DO, Feingold D, Steele SR, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Anal Squamous Cell Cancers (Revised 2018). Dis Colon Rectum 2018;61:755–74. 
                </li><li>Darragh TM, Winkler B. Anal cancer and cervical cancer screening: key differences. Cancer Cytopathol 2011;119:5–19. 
                </li><li>Neukam K, Milanés Guisado Y, Fontillón M, Merino L, Sotomayor C, Espinosa N, et al. High-resolution anoscopy in HIV-infected men: Assessment of the learning curve and factors that improve the performance. Papillomavirus Res 2019;7:62–6. 
                </li><li>Kelly H, Chikandiwa A, Alemany Vilches L, Palefsky JM, de Sanjose S, Mayaud P. Association of antiretroviral therapy with anal high-risk human papillomavirus, anal intraepithelial neoplasia, and anal cancer in people living with HIV: a systematic review and meta-analysis. Lancet HIV 2020;7:e262–78. 
                </li><li>Lin C, Slama J, Gonzalez P, Goodman MT, Xia N, Kreimer AR, et al. Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis. Lancet Infect Dis 2019;19:880–91. 
                </li><li>NYS Guidelines recommendations on anal pap smears [Internet]. [cited 2021 Apr 27]; Disponible <a
                  href="https://www.natap.org/2010/HIV/032510_01.htm"
                  class=""
                  target="_blank"
                  >aquí
                  <span class="icon solid fa-external-link-alt"></span
                ></a>.</li> 
                </li><li>Bosch FX, Robles C, Díaz M, Arbyn M, Baussano I, Clavel C, et al. HPV-FASTER: broadening the scope for prevention of HPV-related cancer. Nat Rev Clin Oncol 2016;13:119–32. 
                </li><li>Toft L, Tolstrup M, Storgaard M, Ostergaard L, Søgaard OS. Vaccination against oncogenic human papillomavirus infection in HIV-infected populations: review of current status and future perspectives. Sex Health 2014;11:511–23. 
                </li><li>Kelly H, Faust H, Chikandiwa A, Ngou J, Weiss HA, Segondy M, et al. Human Papillomavirus Serology Among Women Living With HIV: Type-Specific Seroprevalence, Seroconversion, and Risk of Cervical Reinfection. J. Infect. Dis. 2018;
                </li><li>Schiller JT, Castellsagué X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 2012;30 Suppl 5:F123-138. 
                </li><li>World Health Organization. Comprehensive cervical cancer control: a guide to essential practice. 2nd ed. 2014. 
                </li><li>Liao JB, Fisher CE, Madeleine MM. Gynecologic cancers and solid organ transplantation. Am J Transplant 2019;19:1266–77. 
                </li><li>Schiffman M, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, et al. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers 2016;2:16086. 
                </li>
                </ol>
              <hr />
       <!-- Section -->
       <section class="main">
        <header class="major">
          <h2>MÓDULO 7</h2>
        </header>
        <div class="featuresA">
          <section>
            <a href="M71_1.html"
              ><span class="icon solid fa-female major accent4"></span
            ></a>
            <h3><a href="M71_1.html" class="button">UNIDAD 1</a></h3>
            <a href="M71_1.html"><p>VPH y cáncer de cuello uterino en mujeres con VIH</p></a>
          </section>
          <section>
            <a href="M72_1.html"
            ><span class="icon solid fa-female major accent4"></span
              ></a>
            <h3><a href="M72_1.html" class="button">UNIDAD 2</a></h3>
            <a href="M72_1.html"><p>Mujeres infectadas por el VIH</p></a>
          </section>
          <section>
            <a href="M73.html"
              ><span class="icon solid fa-female major accent4"></span
            ></a>
            <h3><a href="M73.html" class="button">UNIDAD 3</a></h3>
            <a href="M73.html"><p>VPH y cáncer de cuello uterino en mujeres inmunodeprimidas</p></a>
          </section>
       
        </div>
        <hr />

          <header class="major">
            <h2>RECURSOS</h2>
          </header>
          <div class="featuresA">
            <section>
              <a href="M7summary.html"><span class="icon solid fa-star major accent4"></span></a>
              <h3><a href="M7summary.html" class="button">Glosario</a></h3>
            </section>
            <section>
              <a href="M7biblio.html"><span class="icon solid fa-book major accent4"></span></a>
              <h3><a href="M7biblio.html" class="button">Bibliografía</a></h3>
            </section>
            <section>
              <a  href="docs/PDFsample.pdf" target="_blank"><span class="icon solid fa-file major accent4"></span></a>
              <h3><a href="docs/PDFsample.pdf" target="_blank" class="button">PDF</a></h3>
            </section>
          </div>
          <footer id="footer">
            <p class="azul">Patrocinado por:</p>
            <div class="image">
              <img src="images/logoMSD.png" alt="" data-position="" />
            </div>
          </footer>
        </section>
      </div>
    </div>
z

   <!-- Wrapper -->
   <div class="wrapper">
    <div class="inner">
      <!-- Footer -->
      <footer id="footer">
        <div class="image">
          <a href="https://www.e-oncologia.org/" target="_blank"><img src="images/logos.png" alt="" data-position="" /></a>
        </div>
      </footer>
    </div>
  </div>
</div>

<!-- Scripts -->
<script src="assets/js/jquery.min.js"></script>
<script src="assets/js/browser.min.js"></script>
<script src="assets/js/breakpoints.min.js"></script>
<script src="assets/js/util.js"></script>
<script src="assets/js/main.js"></script>
</body>
</html>